Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 15, 2009 (Vol. 29, No. 2)

N Formation Design

URL:www.nformationdesign.com
  • Animations
  • More content needed
This company appears to be specializing in 3-D media and although the main focus seems to be on research and the life sciences, there are other projects on the site. The organelle section, for example, when activated, shows a rotating 3-D image (in Java) of budding yeast with internal organelles. The designers chose to keep the image simple, which is good for educational purposes (for which it is intended), but is disappointing from a technical perspective. Users can click on boxes depicting sub-sections of the image for more info and the entire figure can be rotated and zoomed. Another model of the yeast cell cycle was similarly designed, though it showed an animation of the process instead of a rotating still image. Overall, the quality of the videos was adequate for undergraduate instruction, but there just weren’t enough of them. The company needs to get to work producing more of these for their site to be of broad general interest.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »